Compounds and methods for treating urinary incontinence

Details Compounds and methods for treating urinary incontinence Compounds and methods for treating urinary incontinence

2006-03-28

2006-03-28

Powers, Fiona T. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S312100, C548S333100

Reexamination Certificate

active

07019021

ABSTRACT:
Compounds of the formula (II)wherein R1, R2, R3, R4, and R5are as set forth herein, pharmaceutical compositions containing them, and their use in treating urinary incontinence.

REFERENCES:
patent: 3081222 (1963-03-01), Hagelman et al.
patent: 3202660 (1965-08-01), Zeile et al.
patent: 3931216 (1976-01-01), Franzmair
patent: 4142051 (1979-02-01), Franzmair
patent: 4213995 (1980-07-01), Staehle et al.
patent: 4226713 (1980-10-01), Goldberg
patent: 4226773 (1980-10-01), Kynel
patent: 4287201 (1981-09-01), Olson et al.
patent: 4355033 (1982-10-01), Ramuz
patent: 4461904 (1984-07-01), York, Jr.
patent: 4492709 (1985-01-01), Purcell
patent: 4587257 (1986-05-01), DeSantis et al.
patent: 4596818 (1986-06-01), Newsome et al.
patent: 4644007 (1987-02-01), York, Jr.
patent: 4861189 (1989-08-01), Fukukawa et al.
patent: 4861789 (1989-08-01), Berge et al.
patent: 5130441 (1992-07-01), Gluchowski
patent: 5237032 (1993-08-01), DeMeuse et al.
patent: 5237072 (1993-08-01), Gluchowski
patent: 5380742 (1995-01-01), Servnie et al.
patent: 5480871 (1996-01-01), Spellmeyer et al.
patent: 6268389 (2001-07-01), Esser et al.
patent: 6602897 (2003-08-01), Esser et al.
patent: 6747051 (2004-06-01), Esser et al.
patent: 6858594 (2005-02-01), Esser et al.
patent: 1 929 950 (1970-03-01), None
patent: 2 316 377 (1974-10-01), None
patent: 28 06 811 (1979-08-01), None
patent: 28 54 659 (1980-07-01), None
patent: 0 030 616 (1981-06-01), None
patent: 0 070 084 (1983-01-01), None
patent: 0 081 923 (1983-06-01), None
patent: 0 081 924 (1983-06-01), None
patent: 00/81923 (1983-06-01), None
patent: 0 073 394 (1983-09-01), None
patent: 0 117 102 (1984-08-01), None
patent: 0 236 636 (1987-09-01), None
patent: 0 416 841 (1991-03-01), None
patent: 0464 946 (1992-08-01), None
patent: 0 599 697 (1994-06-01), None
patent: 0 682 028 (1995-11-01), None
patent: 1216945 (1970-12-01), None
patent: 1450250 (1976-09-01), None
patent: WO 88/07995 (1988-10-01), None
patent: WO 94/08040 (1994-04-01), None
patent: WO 95/19968 (1995-07-01), None
Nordling, J., et al; “Sympathetic Influence of Striated Urethral Sphincter in Urinary Incontinence”, Prog. Clin. Biol. Res., vol. 78, pp. 101-103; 1981.
Randall, W.C., et al; “Multiple Central Alpha 1 Adrenoceptors of Avian and Mammalian Species”; Biochem. Pharmacol., vol. 32. No. 12. pp. 1933-1940; 1983.
Kontani, H., et al; “Effects of Adrenergic Agonists on an Experimental Urinary Incontinence Model in Anesthetized Rabbits”; Jpn. J. Pharmacol., vol 58, No. 4 pp. 339-346; 1992.
Van Savage, J.G., et al; “Effects of Alpha-Adrenergic Agonist on Neobladder Water and Elelctrolyty Transport”, Urology, vol. 43, No. 3, pp. 324-327, 1994.

Affiliated with

Also associated with

Rating

Compounds and methods for treating urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and methods for treating urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for treating urinary incontinence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3582774